Purdue Pharma wants a lawsuit dismissed that accuses the company of profiting from the opioid crisis by aggressively marketing OxyContin
The motion to dismiss the suit accuses Massachusetts prosecutors of trying to"vilify Purdue and its employees and directors."A spokesperson for Attorney General Maura Healey confirmed receipt of the motion and plans to oppose it.This is the second motion to dismiss filed by the company's legal defense. The court did not initially rule on the first motion because the Attorney General's office amended the complaint.
The unredacted complaint The unredacted court documents say that Purdue Pharma secretly pursued a plan, dubbed"Project Tango," to become"an end-to-end pain provider" by selling both opioids and drugs to treat opioid addiction. Meanwhile, owners on the board -- members of the Sackler family, one of America's wealthiest -- reaped more than $4 billion in opioid profits.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesOxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address p...
Lire la suite »
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
Lire la suite »
OxyContin maker Purdue Pharma reportedly exploring bankruptcyOxyContin maker Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits, Reuters reports citing people familiar with the matter.
Lire la suite »
Oxycontin-maker Purdue Pharma reportedly exploring bankruptcy amid litigation over opioidsOxyContin-maker Purdue Pharma is exploring filing for bankruptcy amid thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the US, according to Reuters.
Lire la suite »
Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’The suit alleges that Purdue disregarded safety and pushed doctors to prescribe high doses of OxyContin.
Lire la suite »
Why Big Pharma Is Diving Into Gene TherapyBarron's cover story: Big Pharma is diving into gene therapy
Lire la suite »
Deploying drugs for new purposes holds great promiseRepurposing drugs is a cheaper way of fighting diseases
Lire la suite »
UPDATE: Horizon Pharma stock soars 17% premarket on positive trial of eye disease treatment
Lire la suite »
Aurora Cannabis to acquire 51% stake in Portugal's Gaia Pharma, set up medical cannabis facility
Lire la suite »